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The global response to the HIV/AIDS epidemic has improved access to antiretroviral 
therapy (ART) and has contributed to decreased HIV/AIDS morbidity and mortality in 
Sub-Saharan Africa. Patient adherence to ART is crucial to the success of HIV/AIDS 
treatment. However, little is known about the determinants of adherence to ART among 
people living with HIV/AIDS (PLWHA) in the Democratic Republic of Congo (DRC). 
This qualitative study used in-depth semi-structured patient interviews, a purposive 
sampling strategy and thematic analysis scheme to identify barriers and facilitators of 
adherence to ART in the DRC. We recruited three categories of participants from the 
Centre Hospitalier Monkole and the NGO ACS Amo Congo including participants on 
antiretroviral (ARV) treatment (n=19), on ARV re-treatment (n=13) and lost to follow 
up (n=6). Among 38 participants interviewed, 24 were female and the median age was 
41 years. Food insecurity as a barrier to adherence emerged as a dominant theme across 
the three categories of participants. Other barriers included financial constraints, 
forgetfulness and fear of disclosure/stigma. Religious beliefs were both a barrier and 
facilitator to ART adherence. We found that food insecurity was a common and 
important barrier to ART adherence among patients in the DRC. Our findings suggest 
that food insecurity should be appropriately addressed and incorporated into 
antiretroviral treatment programs to ensure patient adherence and ultimately the long-
term success of HIV treatment in the region. 
 
 























Access to antiretroviral therapy (ART) in Sub-Saharan Africa has improved 
considerably over the past several years and has contributed to decreased HIV/AIDS 
morbidity and mortality in the region (Brinkhof et al., 2009; Mills et al., 2011; UNAIDS 
2012). However, in addition to treatment access, high and sustained patient adherence to 
ART is sine qua non for maximizing both its therapeutic and preventive benefits 
(Kalichman et al., 2010; Paterson et al., 2000).  
Prior studies have documented a number of determinants of adherence to ART, 
ranging from economic and structural to socio-cultural factors, as well as factors such as 
the complexity of the regimen, side effects; forgetfulness and inadequate knowledge 
(Badahdah & Pedersen, 2011; Balcha et al., 2010; Curioso et al., 2010; Hardon et al., 
2007; Mills et al., 2006; Mshana et al., 2006; Tsai & Bangsberg, 2011; Tuller et al., 
2010; Wanyama et al., 2007). However, there are still important research gaps which 
need to be addressed. 
Previous studies have not examined adherence to ART among patients with different 
treatment profiles; this approach might allow new insights into factors that constrain 
and facilitate ART adherence. In addition, there is a very limited literature on ART 
adherence in Democratic Republic of Congo (DRC) which remarkably restricts our 
understanding of factors associated with ART adherence, and renders studies on ART 
adherence in the DRC a research priority. 
This qualitative study expands on the current available knowledge and address the 
above cited research gaps by exploring barriers and facilitators of adherence to ART in 
three different groups of participants including those on ART with no history of 
treatment interruption, on ART with history of treatment interruption and those lost to 





The study was conducted in Kinshasa, the DRC in March 2011. Participants were 
recruited from two health facilities, the Centre Hospitalier Monkole (CHM) and the 
NGO Actions Communautaires Sida/Avenir Meilleur pour les Orphelins (ACS/Amo-
Congo) through a maximum variation, purposive sampling strategy (Bowers, House, & 
Owen, 2011). Our participants consisted of 1) participants who successfully completed 
at least 6 months of treatment since antiretroviral (ARV) treatment initiation, herein 
referred as participants on ARV treatment, 2) participants who were on ARV re-
treatment after at least one month of ART interruption, referred to as participants on 
ARV re-treatment, and 3) participants who were lost to follow-up. We considered as 
lost to follow-up, participants who were unable to show up for antiretroviral refills for 
three consecutives months (90 days) after the date of the last medical appointment. To 
be eligible for inclusion in the study, participants had to be at least 18 years old, HIV 
positive, and belong to one of the aforementioned categories. Subjects were recruited 
when they attended the health centers for routine medical examination or when refilling 
their monthly ART prescription. Participants from the lost to follow-up group were 
recruited through phone calls made to mobile numbers that were available on their 
medical files. The research team conducted additional outreach to patients lost to 
follow-up who could not be reached through phone calls, using addresses from medical 
  
files. Upon explaining the purpose of the study and assuring strict confidentiality, all 
participants provided written informed consent and completed a questionnaire on socio-
demographic characteristics prior to conducting interviews. Participants were 
compensated for their time and transportation with an amount of 10 US dollars. This 
study was granted ethical approval from the Committee for Research on Human 
Subjects at Kyoto University and the Kinshasa School of Public Health Ethics Review 
Committee in the DRC. 
 
 
Data collection and analysis 
A literature review of ART adherence informed the development of a semi-structured 
interview guide. The interview guide was designed to explore topics related to 
participants’ experiences, beliefs, behaviors, opinions, and knowledge about HIV/AIDS 
and ART. Probes were used to gain detailed insights and facilitate emergence of new 
themes. Specific questions explored reasons for medication interruption, cues to restart 
ART among participants on ARV re-treatment and reasons for dropping out and barriers 
to restarting ART among patients lost to follow-up. A preliminary insight of data were 
obtained through debriefing sessions conducted at the end of each interview to note the 
main emerging themes and to plan how to address those themes more effectively in 
subsequent interviews. Interviews lasted from 25 minutes to 1 hour and were conducted 
in French and Lingala, the most commonly used languages in Kinshasa.  
Interviews were digitally recorded, then transcribed verbatim and translated into 
English. All the transcripts were reviewed for accuracy by comparing with the 
recordings. Field notes and data set transcripts constituted the final material for analysis. 
Data were manually analyzed using a thematic analysis approach. This approach 
involves getting familiarized with the data through an iterative process of reading the 
data set transcripts, generating initial codes, arranging codes into larger categories, 
drawing connections between codes and categories until generation of a saturated 
thematic map of the analysis (Braun & Clarke, 2006). The analytical process included a 
separate data analysis of participants on ARV treatment, re-treatment and lost to follow-
up, allowing new insights into determinants of ART adherence across the three 
categories of participants. Initially, two investigators (PMM & TT) independently coded 
the transcripts and identified emerging themes relevant to the research question. 
Discrepancies in coding were discussed and resolved by consensus and codes were 
organized into larger categories. In the second phase, codes, and categories were revised 
and refined through regular meetings with an expert panel (MDF, MOK & MK). Quotes 
from the participants are provided in support of the themes we identified and are lightly 
edited for ease of reading. Efforts were made to not substantially alter the contents of 




Description of study participants 
38 participants were interviewed, considering the sample size of 5 to 25 participants 
potentially needed to achieve thematic saturation from previous studies (Creswell, 
2007). 19 participants (50%) were currently on ARV treatment, 13 (34%) on ARV re-
treatment and 6 (16%) were lost to follow-up. The median age of participants was 41 
  
years; most had completed primary education but were without standard employment 
and had a monthly income of less than 20 US dollars. Almost half reported having 
irregular meals (Table 1). 
 
 
Barriers to Adherence 
We found an overall similarity in the pattern of themes that emerged across the three 




Food insecurity was the most common theme that emerged both as a day to day barrier 
to ART adherence among participants from ARV treatment and re-treatment group and 
as one of the principal reasons for ART interruption among participants from the ARV 
re-treatment and lost to follow-up group. Participants described two pathways through 
which food insecurity constrained adherence to ART: 1) experiencing increased ART 
side effects and 2) the belief that ART does not work or is harmful when taken without 
food. Several participants reported experiencing uncomfortable side effects when they 
took medication on an empty stomach. One participant said:  
“It’s very tough to take the pills when there is nothing to eat. I made two weeks I 
was not taking the pills. When I took them without food I had stomach aches.” 
(41 year-old female on ARV treatment) 
The belief that the medicines are not effective or harmful when taken on an empty 
stomach also affected adherence to ART: 
“The only problem is just about eating. You need to eat for this treatment to work. 
If I have no food I don’t take pills. Like today I didn’t take my pills because I 
couldn’t eat.” (35 year-old female on ARV re-treatment) 
“The medication can be good but can also be bad for the body if you take them 
without foods. Taking pills without eating can actually cause much damage in 
your body.” (63 year-old male lost to follow-up) 
Food insecurity was a daily concern and a source of frustration for participants and their 
family members. As one participant stated:  
“I really have financial problems; I don’t know what to do. Sometimes I am just 
fed up, mainly if I have nothing to eat, I get angry and push the pills bottle away 




Another important theme that impacted adherence was financial insecurity. Participants 
expressed difficulty securing money for transportation to attend clinical visits or other 
medical related expenses such as medical tests or clinical examination fees. This 
resulted in some of them missing their medication refill appointments or temporarily 
interrupting their medication. Moreover, we noted that other medical related expenses 
constituted a barrier to restarting ART among patients lost to follow-up. Although both 
health facilities offered ART free of charge, participants still had to pay for other 
ancillary costs. For example, a 48 year-old male participant who interrupted ART after  
relocating in the hinterland of Congo explained his difficulties in restarting the 
  
treatment when he came back to the city of Kinshasa:  
“I was discouraged when I learned from somebody that there (meaning the health 
facility) they ask 25$ for the CD4 test. I was really trying to figure out how to 
take contact with the health facility for restarting my treatment until when you 
contacted me.”(48 year-old male lost to follow-up) 
 
Participants sometimes had to balance between allocating their very limited budget on 
either their medical expenses or on household needs such as paying for children’ 
education or securing food for the household. One participant said: 
“At a certain time I stopped taking my medication because I had many financial 
problems, I had to take care of children’s education and moreover you need to eat 




Forgetfulness was a common reason for skipping doses among participants from all the 
categories. In a few instances, forgetfulness resulted in taking more than the prescribed 
dose. One participant said: 
“Sometimes, it happens that I forget that I have already taken my evening pills; in 
that case I will take another one just to be sure I don’t miss. I notice that when I 
run out of pills before the next appointment for treatment refill and then I just 




Fear of disclosure/stigma 
Participants often did not disclose their HIV status out of fear of rejection and gossip. 
Some participants pointed to stigma as a potential barrier to ART adherence; however, 
this did not affect adherence inasmuch as most of them used coping strategies such as 
taking pills secretly or faking the name of pills when asked. In contrast, a number of 
participants admitted to interrupting their medication out of fear of inadvertently 
disclosing their HIV status. One participant said: 
“I was not here (meaning that she was not at home). I went to live at my 
grandparents’ place; over there they were not aware of my disease, so I didn't 
want them to know” (28 year-old female on ARV re-treatment) 
 
 
Religious and traditional beliefs 
Religious beliefs were both a barrier and a facilitator of ART adherence. The belief that 
one’s disease was caused by witchcraft led a few participants from the ARV re-
treatment and lost to follow-up groups to interrupt their medication and to use prayers 
and/or traditional medicines in search for potential cure. On the other hand, many 
participants sustained the belief that it is God who provided the knowledge to make 
ARVs; this mindset motivated them to keep adhering to the treatment.  
“I am a Christian and a believer, I know that God exists but those medicines also 
were inspired by God. God is the one who gave inspiration to doctors to make 
those medicines for us.” (59 year-old male on ARV treatment) 
  
“Those medicines just give you strength but God is the one who cures. Because it 
is God who gave you intelligence to find out medicines, so through medicines I 
can get cured; before putting the pills in your mouth you must have faith.” (37 




Other reported barriers included travel or migration, feeling hopeless, side effects, and 
the use of traditional medicines. Other participants reported delaying or skipping ART 




This is the first qualitative study to examine ART adherence correlates among HIV-
positive people with different treatment experiences, and the first to examine adherence 
among HIV-infected adults in Kinshasa, DRC. We found that food insecurity was the 
most frequently reported barrier to ART adherence among our participants. Previous 
studies on ART adherence have identified food insecurity as a contributing factor of 
nonadherence to ART, but none of these prior studies examined barriers to ART 
adherence among participants with different treatment experiences (Hardon et al., 2007; 
Nagata et al., 2012; Sanjobo et al., 2008; Weiser et al., 2010). Our study purposively 
selected participants with different treatment profiles, namely participants who were on 
ARV treatment, re-treatment and lost to follow-up. Examining adherence barriers 
exclusively with participants on ARV may reveal only a partial picture of barriers to 
ART adherence; since this group represents participants who have so far managed to 
adhere to treatment so, barriers identified essentially reflect those that interfere with 
day-to-day ART adherence. Thus, knowledge on these two last patients groups is vital 
as poor adherence and ART interruption foster emergence of HIV drug resistance, which, 
besides affecting long-term effectiveness of ART at the individual level, raises serious 
public health implications with potential transmission of drug-resistant strains of HIV 
(Danel et al., 2009; Gupta et al., 2012; Lima et al., 2010; Luebbert et al., 2012). 
Participants reported skipping ART doses in the absence of food; this held true for 
participants in the ARV treatment and re-treatment groups. In addition, participants in 
the ARV re-treatment and lost to follow-up groups identified food insecurity among the 
main reasons for their treatment interruption.   
Food insecurity is associated with a number of adverse health behaviors. For 
instance, a previous study found increased risky sexual behaviors among food insecure 
women in Botswana and Swaziland (Weiser et al., 2007). Moreover, food insecurity was 
shown to be associated with unsuppressed viral load which may lead to treatment failure 
(Wang et al., 2011). These findings suggest that effective strategies to promote food 
access to patients on ART should be implemented in order to curtail the negative effects 
of food insecurity on ART adherence in the DRC. For example, nutritional support to 
food insecure patients was shown to improve both ART adherence and patient retention 
in care in Sub-Saharan Africa (Cantrell et al., 2008).  
Additionally, addressing financial constraints is also critically important in 
improving adherence to ART. These results are in line with a recent study in 
Mozambique which showed that adherence to ART and patient retention in care 
  
improved when patients were organized in small groups, and collected pills for all the 
members on a rotating basis to reduce the cost of transportation (Decroo et al., 2010).  
We also found that stigma and fear of disclosure were barriers to ART adherence. 
Most participants kept their HIV status secret and revealed it only in a very restricted 
social network such as the immediate family. Although patients listed stigma and fear of 
disclosure as a barrier to ART adherence, this did not seem to decrease their actual 
adherence since many of them used strategies such as disguising or taking their 
medication secretly to avoid disclosure. However, such strategies were more difficult to 
sustain over long periods of time in an environment which they considered hostile for 
disclosure; for example when patients relocated to a relative’s home, then resolved to 
interrupt medication to avoid unintentional disclosure.   
We found that religious beliefs were both a barrier and facilitator of ART adherence. 
Previous studies have identified beliefs in spiritual healing and/or beliefs around the 
causes of HIV to impact negatively on ART adherence (Mshana et al., 2006; Roura et al., 
2009; Wanyama et al., 2007). Participants who believed their disease was caused by 
witchcraft interrupted their medication to seek healing through prayers and/or 
traditional medicine. Conversely, some patients thought of ART as an expression of 
God’s knowledge transmitted to care providers, and this was sufficient incentive for 
them to stick with medication. These findings fit with the social context of the DRC 
where religious and spiritual beliefs are essential components of people’s lives (Maman 
et al., 2009). Addressing religious barriers in interventions designed to promote 
adherence to ART in such settings might help to improve patient retention in ART 
programs. Faith-based organizations can positively impact on ART adherence by 
promoting ARVs as a divine tool to fight HIV/AIDS.  
Our study has some limitations. First, there might be a selection bias with 
participants lost to follow-up. A significant number of lost to follow-up were reported 
dead suggesting that those we recruited might represent a specific group of survivors 
with different views and experiences. Second, participants were all selected from 
private health facilities that supplied ARVs free of charge. It is possible that participants 
from the public health sector may offer another picture of barriers of adherence to ART, 
especially in settings where ARVs are not free. Lastly, although we believe that our 
results may be extended to similar settings; it is unclear to what extent they can be 
applied in different contexts in Sub-Saharan Africa.  
However, this study is unique in that it captures diverse perspectives of determinants 
of adherence to ART from participants with different treatment profiles. In addition, we 
found that in response to the same adherence barrier, participants adopted different 
medication-taking behavioral trajectories namely the interruption or just skipping a 
daily dose of their medication. Furthermore, it would not have been possible to unveil 
the negative impact of religious beliefs, travel/migration, feeling hopeless, and 
traditional medicines on ART adherence if we examined adherence only with 
participants in the ARV treatment group.  
     
 
Conclusion 
We found that food insecurity emerged as a common and an important barrier to ART 
adherence among patients in the DRC. HIV treatment and care programs should 
comprehensively address food insecurity in the context of other socio-cultural related 
  
factors to ensure patient adherence to ART and ultimately long-term success of HIV 
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Table 1. Sample characteristics 
Variable N=38 % 
Age in years (Median)  41   
Gender     
Male  14 36.8 
Female 24 63.2 
Marital status     
Single, Separated 13 34.2 
Married, Cohabitating 21 55.3 
Widow/Widower 4 10.5 
Treatment category     
On ARV treatment 19 50.0 
On ARV re-treatment 13 35.2 
Lost to follow-up 6 15.8 
Education level     
None  2 5.3 
Primary 8 21.1 
Secondary 20 52.6 
University 8 21.1 
Profession     
with employment 13 34.2 
without employment 25 65.8 
Monthly income     
<20$ 17 44.7 
20$-100$ 17 44.7 
>100$ 4 10.5 
Meal/day     
Regular (≥ 2 meals) 22 57.9 

























Table 2. Summary of themes by treatment category   
Themes  Treatment category  
  On ARV treatment On ARV re-treatment Lost to follow-up 
Food insecurity ✓- ✓- ✓- 
Financial insecurity ✓- ✓- ✓- 
Forgetfulness ✓- ✓- ✓- 
Fear of disclosure/stigma ✓- ✓- ✓- 
Religious beliefs ✓+   ✓- /+ ✓- 
Others:    
Travel/migration   ✓- ✓- 
Feeling hopeless  ✓- ✓- 
Side effects ✓- ✓- ✓- 
Alcohol ✓-  ✓- 
Traditional medicines  ✓- ✓- 
✓ indicates in rank order the themes that emerged and affected ART adherence 
- indicates a barrier of adherence to ART 
+ indicates a facilitator of adherence to ART 
 
 
